Carlo Baraldi - Concepedia

Author

Carlo Baraldi

University of Modena and Reggio Emilia ORCID

Also Known As

Alberto Chiarugi, C Baraldi, C. Baraldi, Carlo Baraldi

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

University of Modena and Reggio Emilia Azienda Ospedaliero-Universitaria di Modena Istituti di Ricovero e Cura a Carattere Scientifico University of L'Aquila Istituto delle Scienze Neurologiche di Bologna

About

Carlo Baraldi is an author at University of Modena and Reggio Emilia specializing in medicine, neurology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	241
2	Health Sciences	1	1	20
3	Public Health	1	1	13
4	Allergy	1	1	20
5	Endocrinology	1	1	26

Carlo Baraldi

Publications

787

Citations

H-Index

Page 1

	Year	Citations
Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatment Simona Guérzoni, Lanfranco Pellesi, Carlo Baraldi, The Journal of Headache and Pain	2016	56
Predictors of response to erenumab after 12 months of treatment Carlo Baraldi, Flavia Lo Castro, Maria Michela Cainazzo, Brain and Behavior	2021	56
Hair testing in clinical setting: Simultaneous determination of 50 psychoactive drugs and metabolites in headache patients by LC tandem MS Manuela Licata, Cecilia Rustichelli, Federica Palazzoli, Journal of Pharmaceutical and Biomedical Analysis Cluster HeadacheLc Tandem MsPsychiatryMedicineDrug Test	2016	53
Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy Simona Guérzoni, Lanfranco Pellesi, Carlo Baraldi, Frontiers in Neurology	2017	53
Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache Umberto Pensato, Carlo Baraldi, Valentina Favoni, Neurological Sciences Real-life AssessmentCluster HeadacheMedication Overuse HeadachePsychiatryRefractory Chronic Migraine	2021	51
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study Raffaele Ornello, Carlo Baraldi, Simona Guérzoni, The Journal of Headache and Pain	2022	45
Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache Umberto Pensato, Carlo Baraldi, Valentina Favoni, Cephalalgia	2022	36
Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data Raffaele Ornello, Simona Guérzoni, Carlo Baraldi, The Journal of Headache and Pain	2020	35
Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study Cecilia Rustichelli, Elisa Bellei, Stefania Bergamini, Cephalalgia	2020	30
Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study Maria Michela Cainazzo, Carlo Baraldi, Anna Ferrari, Neurological Sciences Chronic MigraineCluster HeadacheMedication Overuse Headache12-Month Real-life StudyPharmacology	2021	30

Page 1